Non-Euclidean geometry

Sharon Personal Care to Introduce Groundbreaking, 100% Natural Emollient at in-cosmetics 2024

Retrieved on: 
Jeudi, avril 11, 2024

Sharofeel DS hydrates and improves skin softness, flexibility, and smoothness, with proven benefits for haircare

Key Points: 
  • Sharofeel DS hydrates and improves skin softness, flexibility, and smoothness, with proven benefits for haircare
    Trezzo sull'Adda, Italy--(Newsfile Corp. - April 11, 2024) - Sharon Personal Care, a global supplier of innovative, environmentally friendly ingredient solutions for a broad range of personal care products, is set to introduce Sharofeel DS, a revolutionary, 100% natural emollient at in-cosmetics 2024, taking place April 15-20 in Paris.
  • Derived from succinic acid and 2-octyl dodecanol, Sharofeel DS improves natural moisturization, skin softness, flexibility and smoothness—elevating skincare formulations with its sophisticated sensory profile.
  • "Sharofeel DS marks a significant milestone for Sharon Personal Care and our commitment to innovation in the personal care industry," says Naama Eylon, CEO of Sharon Personal Care.
  • During in-cosmetics 2024, Sharon Personal Care will be providing demonstrations of Sharofeel DS as well as SharoHYAL® Moringa , an innovative haircare technology they will unveil at the show.

ATOMO COFFEE SECURES PRESTIGIOUS PARTNER FOR FIRST MAJOR ROLLOUT OF INNOVATIVE BEANLESS ESPRESSO

Retrieved on: 
Vendredi, avril 12, 2024

Starting in August, Bluestone Lane will begin offering Atomo’s “beanless” espresso at all 58 locations nationwide.

Key Points: 
  • Starting in August, Bluestone Lane will begin offering Atomo’s “beanless” espresso at all 58 locations nationwide.
  • Atomo crafted its espresso by replicating the exact molecular structure of conventional coffee sourced from upcycled, farm-grown superfoods such as date seeds, guava and sunflower.
  • The espresso delivers a healthier alternative that’s high in antioxidants, lower in acidity with a cleaner caffeine experience.
  • “We’re thrilled to introduce Atomo’s beanless espresso across all Bluestone Lane locations,” said Nicholas Stone, CEO of Bluestone Lane.

Introducing JooY, A NEW Innovative Scalp Care Brand Powered by Fermented Superfoods and Rooted in Asian Herbal Therapy

Retrieved on: 
Jeudi, avril 25, 2024

Born from a century old recipe of Fermented Superfoods, JooY powers a new scalp care solution.

Key Points: 
  • Born from a century old recipe of Fermented Superfoods, JooY powers a new scalp care solution.
  • 96.2% agreed JooY Soothing Scalp Serum absorbs into scalp without leaving a greasy or sticky residue, improves scalp hydration and effectively relieves scalp irritation and discomfort.
  • 92.3% agreed that JooY Resurfacing Scalp Serum exfoliated and removed dead skin cells from their scalp and improved scalp texture and smoothness.
  • Full-size pricing are as follows: Clarify Shampoo $29; Clarify Conditioner $29; Soothing Scalp Serum $48; Scalp Resurfacing Serum $42; Scalp Energizing Brush $24.

11 Years After Boston Marathon Bombing, Base Molecular Resonance™ Technologies Offers a Safer Future for the Public

Retrieved on: 
Lundi, avril 22, 2024

Today, Base Molecular Resonance™ Technologies, LLC (BMRT) stands at the forefront of revolutionizing public safety and security.

Key Points: 
  • Today, Base Molecular Resonance™ Technologies, LLC (BMRT) stands at the forefront of revolutionizing public safety and security.
  • Their groundbreaking, patented technology promises heightened safety measures for events like the Boston Marathon through a straightforward scanning process.
  • Demonstrated success extends to encompassing every element on the periodic table and up to 200 types of cancer and other diseases.
  • New innovations like Base Molecular Resonance™ technology undoubtedly bolsters law enforcement efforts in preventing tragedy and protecting our communities into the future."

FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

Retrieved on: 
Dimanche, avril 7, 2024

SHANGHAI, April 7, 2024 /PRNewswire/ -- Dizal (688192.SH) today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD) to its sunvozertinib as the first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations.

Key Points: 
  • SHANGHAI, April 7, 2024 /PRNewswire/ -- Dizal (688192.SH) today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD) to its sunvozertinib as the first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations.
  • This Breakthrough Therapy Designation (BTD) approval was based on results from the global multi-center phase I/II study (WU-KONG1).
  • This new BTD will enable us work more closely with the FDA and accelerate its clinical development and regulatory submission."
  • Affecting roughly 2%-4% of NSCLC patients, EGFR Exon20ins mutations have been difficult to treat due to their unique spatial conformation, diverse mutation subtypes, and high heterogeneity.

The French-American Entrepreneurship Award (FAEA) launches the 15th Edition of its Startup Competition; Accepting Entries from March 18th to May 7th, 2024

Retrieved on: 
Mercredi, mars 6, 2024

The French-American Entrepreneurship Award (FAEA) is thrilled to announce the launch of the 2024, and 15th, edition of its leading startup competition.

Key Points: 
  • The French-American Entrepreneurship Award (FAEA) is thrilled to announce the launch of the 2024, and 15th, edition of its leading startup competition.
  • Since 2008, the FAEA has remained dedicated to fostering awareness and development of high-potential U.S.-based early-stage startups founded by French entrepreneurs.
  • Over the years, hundreds of entrepreneurs have applied to the FAEA across all industries, with a handful winning this precious recognition, and many becoming successful ventures.
  • Applications must be submitted via the website between March 18th and May 7th, 2024.

Groundbreaking Technology from Base Molecular Resonance™ Technologies Will Change Medical, Security, and Military Sectors with a Single Scan

Retrieved on: 
Mardi, février 13, 2024

This groundbreaking technology utilizes resonant frequencies to detect particle interactions at subatomic levels and can detect any substance based on its nuclear composition.

Key Points: 
  • This groundbreaking technology utilizes resonant frequencies to detect particle interactions at subatomic levels and can detect any substance based on its nuclear composition.
  • Every molecular structure, from narcotics to gunpowder to cancer, emits a resonant frequency that is detectable using the company's revolutionary technology, according to BMRT CEO & Co-Founder Robert "Bo" Short.
  • "Utilizing a special transmitter and receiver, our device sends and receives frequencies specific to those materials being targeted," said Short.
  • BMRT is currently negotiating agreements in the medical, security, and military sectors, and expects to launch devices into the marketplace within the next two years.

Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor

Retrieved on: 
Mardi, février 6, 2024

APR-1051 is an oral inhibitor of WEE1 kinase, which plays important role in cell cycle regulation and DNA damage repair.

Key Points: 
  • APR-1051 is an oral inhibitor of WEE1 kinase, which plays important role in cell cycle regulation and DNA damage repair.
  • * Aprea has conducted extensive pre-clinical studies with APR-1051, which have demonstrated that the molecule may have highly potent anti-tumor activity, with a potentially favorable pharmacokinetic (PK) profile.
  • “Submission of an IND represents an important milestone for our APR-1051 development program,” said Dr. Oren Gilad, President and CEO of Aprea.
  • “APR-1051 is a next generation inhibitor of WEE1 kinase and, based on its unique characteristics, we believe it will be best in class.

Fragrance ingredient exposure is orders of magnitude below thresholds of concern, study shows

Retrieved on: 
Mardi, février 6, 2024

MAHWAH, N.J., Feb. 6, 2024 /PRNewswire/ -- The Research Institute for Fragrance Materials, Inc. (RIFM), in collaboration with scientific modeling, data analytics, and computing company Creme Global, compared the fragrance exposure of the highest-end product users to the Threshold of Toxicological Concern (TTC) and Dermal Sensitization Threshold (DST) to determine a realistic understanding of consumer exposure to fragrance. The TTC is based on the U.S. Food and Drug Administration's Threshold of Regulation, which it expands upon to include consideration of an ingredient's molecular structure in conjunction with its toxicity data. The TTC approach is internationally recognized by regulators including the European Food Safety Authority (EFSA).

Key Points: 
  • The TTC approach is internationally recognized by regulators including the European Food Safety Authority (EFSA) .
  • The study authors compared exposure to the approximately 3,000 in-use fragrance-producing ingredients to their respective TTCs and DSTs.
  • Representative fragrance ingredients were randomly selected and analyzed for exposure distribution by product type (i.e., personal, household, oral, and air care) and route of exposure.
  • Exposure calculations were performed by the Creme-RIFM Aggregate Exposure model, which provides realistic exposure estimates that consider all fragrances the population is exposed to across all products used.

Chevron Lummus Global and Hongrun Petrochemical Successfully Commission The World's Largest All-Hydroprocessing White Oil Unit

Retrieved on: 
Mercredi, janvier 31, 2024

RICHMOND, Calif., Jan. 31, 2024 /PRNewswire/ -- Chevron Lummus Global LLC (CLG) today announced the successful commissioning of the world's largest white oil hydroprocessing unit for Hongrun Petrochemical (Weifang) Co., Ltd. in Weifang, Shandong Province, China.

Key Points: 
  • RICHMOND, Calif., Jan. 31, 2024 /PRNewswire/ -- Chevron Lummus Global LLC (CLG) today announced the successful commissioning of the world's largest white oil hydroprocessing unit for Hongrun Petrochemical (Weifang) Co., Ltd. in Weifang, Shandong Province, China.
  • The new plant, which utilizes CLG's ISODEWAXING and ISOFINISHING technologies, consists of two units: a 500,000 metric tons per annum (MTPA) nameplate capacity API Group III lubricating base oil unit with the capability to produce industrial-grade white oil, and a 200,000 metric tons per annum nameplate capacity food grade white oil unit.
  • White oil is a highly refined mineral oil that is used in a wide variety of applications, including pharmaceuticals, cosmetics, food processing and industrial lubricants.
  • Food-grade white oil is a special type of white oil that is manufactured to meet the strict purity requirements of the food and beverage industry.